Results 91 to 100 of about 27,161 (265)

An ETH‐LAD trip with unfavourable consequences: A case report

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Numerous analogues of the psychedelic and internationally controlled hallucinogen LSD have been described; however, only a limited number have been systematically investigated. This report presents the first case with an analytically confirmed ingestion of ETH‐LAD (6‐ethyl‐6‐nor‐lysergic acid diethylamide), the N‐ethyl derivative of LSD.
Johannes Nadler   +6 more
wiley   +1 more source

State of knowledge of Cameroonian drug prescribers on pharmacovigilance

open access: yesThe Pan African Medical Journal, 2015
INTRODUCTION: the present study conducted in Cameroon from June 2013 to February 2014 aimed to estimating the level of pharmacovigilance knowledge and practice of health professionals in Cameroon.
Francis Nde   +3 more
doaj   +1 more source

A White Paper on Advancing Long‐Acting Therapeutics for Maternal and Pediatric Health by Bridging Gaps in Clinical Research, Access and Regulation

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
As use cases for long‐acting therapeutics expand across clinical indications, there is a critical need to ensure the inclusion of women who are pregnant or breastfeeding, infants and children—populations with a historical gap in the availability of interventions already approved for use in adults.
Moherndran Archary   +59 more
wiley   +1 more source

The magnitude of sensitization of pharmacovigilance among undergraduate medical students in a tertiary care teaching hospital – A questionnaire based study [PDF]

open access: yesAl Ameen Journal of Medical Sciences
Background: Pharmacovigilance (PV) is an evolving branch of medical education. It helps in identifying the negative effects of drugs and safeguards the public and patients from them.
Mrutyunjay Mirje   +3 more
doaj  

IJCM_245A: Beyond the Basics: Insights into Pharmacovigilance Literacy among Postgraduate Medical students: A Mixed-Methods study from central India.

open access: yesIndian Journal of Community Medicine
Background: Pharmacovigilance ensures medical intervention safety by detecting, assessing, understanding, and preventing adverse drug effects or related issues.
Darshan Ashok Wath   +3 more
doaj   +1 more source

PHARMACOVIGILANCE STUDIES ON ANTIDIABETIC MEDICATIONS

open access: yes
Diabetes Mellitus (DM) is a significant global health issue, particularly Type 2 DM,which is exacerbated by lifestyle factors like obesity and physical inactivity.The study aims to assess the prescription patterns,common adverse drug reactions among diabetic patients,especially those receiving muiltiple medications,To better understand their health ...
openaire   +2 more sources

A British Pharmacological Society Position Statement on Medications in Pregnancy and Lactation

open access: yes
British Journal of Clinical Pharmacology, EarlyView.
Agnesa Mustafa   +14 more
wiley   +1 more source

Digital Transformation of Medicines Regulation in Africa—Perspectives from a Stakeholder Convening

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Regulatory authorities worldwide are developing strategies to integrate artificial intelligence (AI) into the lifecycle of health products, technologies, and medicines. While regulators share goals of improving efficiency, strengthening decision‐making, and protecting public health, their approaches differ according to institutional structures ...
Christelna Reyneke   +12 more
wiley   +1 more source

TO STUDY THE PHARMACOVIGILANCE OF THE ASPIRIN

open access: yesInternational Research Journal of Modernization in Engineering Technology and Science, 2022
openaire   +1 more source

Regulatory Research Priorities for AI Use in the Medicine Lifecycle: A European Perspective with Global Relevance

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Regulatory bodies play a central role in providing guidance that enables safe and effective use of artificial intelligence tools in medicine development and evaluation. Regulators can also act as catalysts for regulatory science research. To inform these efforts, a European‐wide survey was conducted to solicit stakeholder perspectives on the priority ...
Luis C. Pinheiro   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy